Literature DB >> 20528146

Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging.

Svetlana Halfon1, Natalie Abramov, Borislava Grinblat, Irene Ginis.   

Abstract

Expansion of plastic-adherent bone marrow-derived mesenchymal stem cells (MSCs) results in gradual loss of osteogenic potential after passage 5-6. One explanation is contamination of MSC cultures with mature cells including fibroblasts. Identification and elimination of fibroblasts from MSC cultures could improve MSC yield and differentiation potential and also prevent tumor formation after MSC transplantation. However, no specific markers currently exist that can reliably discriminate between MSCs and fibroblasts. Flow cytometry analysis demonstrated that markers currently used to define MSCs, such as CD105, CD166, CD90, CD44, CD29, CD73, and CD9, are also expressed on human skin or lung fibroblasts. However, the level of expression of CD166 was significantly higher and that of CD9 was significantly lower in MSCs than in fibroblasts. CD146 was expressed only in MSCs. Using small focused microarrays, new markers differentially expressed in MSCs and fibroblasts were identified. Real-time polymerase chain reaction confirmed that expression of CD106, integrin alpha 11, and insulin-like growth factor-2 in MSCs was at least 10-fold higher than in fibroblasts; whereas expression of matrix metalloproteinase 1 and matrix metalloproteinase 3 was almost 100-fold lower. Flow cytometry and immunostaining demonstrated that CD106 protein expression on cell surface could be upregulated in MSCs but not in fibroblasts by the treatment with tumor necrosis factor-alpha. Comparison of surface expression of commonly used and newly identified MSC markers in MSCs cultures of passage 2 and passage 6 demonstrated that CD106 (with and without tumor necrosis factor-alpha treatment), integrin alpha 11, and CD146 were downregulated in MSCs of passage 6, and CD9 was upregulated; whereas all other markers did not change. Newly identified markers that have robust differences of expression in MSCs and fibroblasts on gene and protein level could be used for quality control of MSC cultures after expansion, cryopreservation, gene transfection, and other manipulations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528146     DOI: 10.1089/scd.2010.0040

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  145 in total

1.  Intrinsic growth deficiencies of mesenchymal stromal cells in myelodysplastic syndromes.

Authors:  Carmen Mariana Aanei; Pascale Flandrin; Florin Zugun Eloae; Eugen Carasevici; Denis Guyotat; Eric Wattel; Lydia Campos
Journal:  Stem Cells Dev       Date:  2011-10-27       Impact factor: 3.272

2.  Scaffold-free and scaffold-assisted 3D culture enhances differentiation of bone marrow stromal cells.

Authors:  Prasanna Vidyasekar; Pavithra Shyamsunder; Sanjeeb Kumar Sahoo; Rama Shanker Verma
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-11-05       Impact factor: 2.416

3.  Proteome changes during bone mesenchymal stem cell differentiation into photoreceptor-like cells in vitro.

Authors:  Yu Hong; Guo-Xing Xu
Journal:  Int J Ophthalmol       Date:  2011-10-18       Impact factor: 1.779

4.  Tendon stem cells: experimental and clinical perspectives in tendon and tendon-bone junction repair.

Authors:  Pauline Po Yee Lui; On Tik Wong
Journal:  Muscles Ligaments Tendons J       Date:  2012-10-16

5.  Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide.

Authors:  Ruben A Ferrer; Manja Wobus; Catrin List; Rebekka Wehner; Claudia Schönefeldt; Barbara Brocard; Brigitte Mohr; Martina Rauner; Marc Schmitz; Maik Stiehler; Gerhard Ehninger; Lorenz C Hofbauer; Martin Bornhäuser; Uwe Platzbecker
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

6.  Proteomic Profiling of Native Unpassaged and Culture-Expanded Mesenchymal Stromal Cells (MSC).

Authors:  Erika Moravcikova; E Michael Meyer; Mirko Corselli; Vera S Donnenberg; Albert D Donnenberg
Journal:  Cytometry A       Date:  2018-09-13       Impact factor: 4.355

7.  Human trabecular meshwork cells exhibit several characteristics of, but are distinct from, adipose-derived mesenchymal stem cells.

Authors:  Joshua T Morgan; Joshua A Wood; Naomi J Walker; Vijay Krishna Raghunathan; Dori L Borjesson; Christopher J Murphy; Paul Russell
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-23       Impact factor: 2.671

8.  Variation in primary and culture-expanded cells derived from connective tissue progenitors in human bone marrow space, bone trabecular surface and adipose tissue.

Authors:  Maha A Qadan; Nicolas S Piuzzi; Cynthia Boehm; Wesley Bova; Malcolm Moos; Ronald J Midura; Vincent C Hascall; Christopher Malcuit; George F Muschler
Journal:  Cytotherapy       Date:  2018-02-01       Impact factor: 5.414

Review 9.  Chasing the recipe for a pro-regenerative immune system.

Authors:  James W Godwin; Alexander R Pinto; Nadia A Rosenthal
Journal:  Semin Cell Dev Biol       Date:  2016-08-10       Impact factor: 7.727

10.  Cell-surface expression of neuron-glial antigen 2 (NG2) and melanoma cell adhesion molecule (CD146) in heterogeneous cultures of marrow-derived mesenchymal stem cells.

Authors:  Katie C Russell; H Alan Tucker; Bruce A Bunnell; Michael Andreeff; Wendy Schober; Andrew S Gaynor; Karen L Strickler; Shuwen Lin; Michelle R Lacey; Kim C O'Connor
Journal:  Tissue Eng Part A       Date:  2013-05-30       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.